Cancer News and Research

Latest Cancer News and Research

Eurotrans-Bio awards 1.1 million grant to MDxHealth, NovioGendix for bladder cancer program

MDxHealth SA, a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that together with partner NovioGendix B.V., a molecular diagnostics company spun out from Radboud University Nijmegen Medical Centre, the Netherlands, has received a USD 1.1 million grant from Eurotrans-Bio to progress its bladder cancer program.

3 May 2011

Ipsen first quarter sales increase 6.1% to €285.8 million

Ipsen reported today its sales for the first quarter 2011.

3 May 2011

Study shows how secondhand smoke may increase vulnerability to nicotine addiction

Exposure to secondhand smoke, such as a person can get by riding in an enclosed car while someone else smokes, has a direct, measurable impact on the brain-and the effect is similar to what happens in the brain of the person doing the smoking.

3 May 2011

Guided Therapeutics launches LuViva Advanced Cervical Scan

Guided Therapeutics, Inc., unveiled the new name and new industrial design for its non-invasive and painless test for the early detection of cervical precancer.

3 May 2011

FDA approves new targeted therapy to treat men with advanced prostate cancer

The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.

3 May 2011

McMaster receives new Canadian Cancer Society grants for groundbreaking research

Three cancer studies led by Hamilton researchers are among 52 new research projects worth close to $22 million announced by the Canadian Cancer Society.

3 May 2011

Scientists discover new gene underlying angle-closure glaucoma

Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.

3 May 2011

Statins can help reduce lung damage in severe abdominal sepsis

Statins may be best known for their ability to reduce cholesterol, but a research report appearing in the May 2011 issue of the Journal of Leukocyte Biology shows that these same drugs could also play a crucial role in the reduction of lung damage resulting from severe abdominal sepsis and infection.

3 May 2011

New insight into itch and pain

A new study of itch adds to growing evidence that the chemical signals that make us want to scratch are the same signals that make us wince in pain.

3 May 2011

IASIS Healthcare acquires St. Joseph Medical Center

IASIS Healthcare LLC today announced the completion of its acquisition of a 79% ownership interest in St. Joseph Medical Center a 792 licensed bed facility in downtown Houston, Texas.

3 May 2011

New antioxidant may prevent liver damage in chronic alcoholics

An antioxidant may prevent damage to the liver caused by excessive alcohol, according to new research from the University of Alabama at Birmingham.

3 May 2011

Pregnant women with H1N1 more likely to have low birth weight baby

In 2009, the United States was gripped by concern for a new winter threat: the H1N1 strain of influenza. According to research conducted through that winter, pregnant women were right to be concerned.

3 May 2011

Caliper first quarter revenue increases 25% to $35.8 million

Caliper Life Sciences, Inc., today reported its financial results for the first quarter of 2011. First quarter revenue increased to $35.8 million, or 25%, from $28.7 million in the same period of 2010.

2 May 2011

Watson launches Generess Fe low-dose oral contraceptives in the U.S.

Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.

2 May 2011

USPSTF recommendations negatively impact yearly mammograms among 40-49 year old women

Two new studies reveal that the United States Preventative Services Task Force's recommendation to no longer screen women ages 40-49 for breast cancer using mammograms has begun to negatively affect the number of yearly mammograms performed in this age group and thus decrease the benefits of early detection.

2 May 2011

FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment

Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications for brentuximab vedotin, including one for the treatment of patients with relapsed or refractory Hodgkin lymphoma and one for the treatment of patients with relapsed or refractory systemic anaplastic large cell lymphoma.

2 May 2011

Humana reports EPS of $1.86 for quarter ended March 31, 2011

Humana Inc. today reported diluted earnings per common share for the quarter ended March 31, 2011 of $1.86, compared to $1.52 per share for the quarter ended March 31, 2010.

2 May 2011

Survey underscores education importance on risks of tanning in young women

Despite repeated warnings from dermatologists on the health dangers of tanning, results of a new survey by the American Academy of Dermatology confirmed that a large percentage of Caucasian teen girls and young women admitted using tanning beds or intentionally tanning outdoors in the past year.

2 May 2011

VA develops FATE survey to access treatment quality at the end of patients' lives

Though there have been significant improvements in the treatment of head and neck cancer, there is still a lack of data on the experience of end of life care for head and neck cancer patients, according to a new study published in the May 2011 issue of Otolaryngology-Head and Neck Surgery.

2 May 2011

CTI deposits $10.6 million with U.S. Bank National Association, completes retirement of 7.5% convertible senior notes

Cell Therapeutics, Inc. today announced that it has deposited $10.6 million in cash as trust funds with U.S. Bank National Association, as the trustee of the outstanding 7.5% convertible senior notes, which is an amount sufficient to pay and discharge the entire amount due on the Notes, including accrued and unpaid interest.

2 May 2011

Cancer News and Research

Latest Cancer News and Research

Eurotrans-Bio awards 1.1 million grant to MDxHealth, NovioGendix for bladder cancer program

Ipsen first quarter sales increase 6.1% to €285.8 million

Study shows how secondhand smoke may increase vulnerability to nicotine addiction

Guided Therapeutics launches LuViva Advanced Cervical Scan

FDA approves new targeted therapy to treat men with advanced prostate cancer

McMaster receives new Canadian Cancer Society grants for groundbreaking research

Scientists discover new gene underlying angle-closure glaucoma

Statins can help reduce lung damage in severe abdominal sepsis

New insight into itch and pain

IASIS Healthcare acquires St. Joseph Medical Center

New antioxidant may prevent liver damage in chronic alcoholics

Pregnant women with H1N1 more likely to have low birth weight baby

Caliper first quarter revenue increases 25% to $35.8 million

Watson launches Generess Fe low-dose oral contraceptives in the U.S.

USPSTF recommendations negatively impact yearly mammograms among 40-49 year old women

FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment

Humana reports EPS of $1.86 for quarter ended March 31, 2011

Survey underscores education importance on risks of tanning in young women

VA develops FATE survey to access treatment quality at the end of patients' lives

CTI deposits $10.6 million with U.S. Bank National Association, completes retirement of 7.5% convertible senior notes

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in